Cerba Research

🎀 October is Breast Cancer Awareness Month 🎀 Early detection and treatment advancements have significantly increased survival rates, giving millions hope. At Cerba Research, we are proud to play a role in the fight against breast cancer by providing specialty laboratory services for oncology trials, from preclinical studies to phase 3 trials and beyond. #BreastCancerAwareness #ResearchForACure #EarlyDetection #BiomarkerResearch #CerbaResearch

We are thrilled to announce that Karthikeyan Devaraju will present at the ESGCT Conference, October 22 & 24. Make sure to attend our poster presentation speaking slots: Precision Mapping Viral Integration Landscapes with CRISPR-Cas9 and Long-Read Sequencing (Poster number P0513) Poster Session I on Tuesday, 22 October, from 19:30 to 21:00 Monitoring adenoviral gene therapy safety (Poster number P0981) Poster Session III on Thursday, 24 October, from 14:00 to 15:30 Learn more about our presence at ESGCT here: https://lnkd.in/eEJA2hXv #ESGCT #CellAndGeneTherapy #SpecialtyLab #CerbaResearch

We are excited to announce that Martin Roberge, Ph.D. will present at the Immunogenicity & Bio Assay Summit in Washington DC on October 17th. Make sure to attend our speaking slot 'Tailoring ADA and NAb assays to different drug modalities: Insights from case studies'. Podium Presentation, Thursday, October 17, 2024 at 9:00 AM Track: C1A: Immunogenicity Assessment & Clinical Relevance Read more about our presence at the Immunogenicity and Bioassay Summit here: https://lnkd.in/dhCvQ5qj Please contact me via my Linked profile: Roberge Martin for any further questions. #bioanalysistesting #immunogenicitytesting #biomarkerservices #specialtylabservices #CerbaResearch

Are you wondering how Cerba Research performs intracellular cytokine staining to assess T-cell response by flow cytometry? Nithianandan Selliah, Ph.D, Christopher Rota, and Manpreet Singh will present insights with the poster “Development and global validation of a clinical flow cytometry testing protocol for assessing functional T cell responses using intracellular cytokine staining” at ICCS 2024. Let’s connect and explore how Cerba Research can support your compound development journey with world class specialty and central laboratory services.

Today, on Child Health Day, we reaffirm our commitment to advancing pediatric healthcare through groundbreaking research and innovation. At Cerba Research, we understand that the future of global health begins with the well-being of our children. From vaccine development to diagnostics, we are dedicated to supporting life-changing solutions that protect and nurture the health of children around the world. Together with our partners, we strive to ensure that every child has the opportunity to grow up healthy and thrive. Let’s continue working together to make a difference - because every child deserves a healthy future. #ChildHealthDay #GlobalHealth #FutureOfHealth

Performing a high-dimensional flow cytometry assay requires a precise and tailor-made execution, especially in clinical trials. Nithianandan Selliah, Ph.D, Christopher Rota, and Manpreet Singh will present the latest advancement in high-dimensional flow cytometry with the poster “Optimization, Validation and Implementation of a 25-color Flow Cytometry Assay on Cytek® Aurora Instrument to Monitor Immune Cells in Whole Blood for Multi-Location Clinical Trials.” at ICCS 2024. Let’s connect and explore how Cerba Research can support your journey in developing your compound! 

Do you wonder how you can improve the testing of your clinical samples using flow cytometry? Nithianandan Selliah, Ph.D, Christopher Rota, and @Manpreet Singh will gladly answer this question by presenting the poster “Process Improvement in Clinical Sample Testing with Quality Checks and Efficient Workflow for Global Clinical Trials” at ICCS 2024. Let’s connect and explore how Cerba Research can support your compound development journey with world class specialty and central laboratory services.

Reminder: The Annual International Clinical Cytometry Society (ICCS) 2024 meeting starts tomorrow in Seattle, WA! Cerba Research is excited to participate and engage with top experts in the field. Don't miss our 3 poster presentations, where Nithianandan Selliah, Ph.D, Christopher Rota, and Manpreet Singh will be on-site to discuss: Advancements in clinical sample testing Optimizing high-dimensional flow cytometry assays Functional T-cell response via intracellular cytokine testing Let’s connect and explore how Cerba Research can support your compound development with world-class specialty and central lab services!

We're thrilled to share that Marta Murreddu, PhD will be presenting at the World Vaccine Congress Barcelona 2024! Date: Wednesday, October 30th Time: 11:10 - 11:25 hrs Topic: "Assay Development Advancements in Human Metapneumovirus (hMPV) Vaccine Research" This presentation will showcase groundbreaking innovations that demonstrate our unwavering commitment to advancing research in immunology and infectious diseases. Cerba Research is looking forward to connecting with industry leaders and continuing the conversation on accelerating progress in vaccine development!

We are proud to be part of World Vaccine Congress Europe. Make sure to attend our speaking slots presented by Marta Murreddu, PhD “Assay Development Advancements in Human Metapneumovirus (hMPV) Vaccine Research” and “Compliance in Supply Chain & Logistics Operations: Make or Break Your Clinical Trial“ presented by Marc Van Pruijssen. Meet team Cerba Research Booth 58 ! #Worldvaccinecongresseurope #vaccinetesting #vaccinelab